5 Key Takeaways

• 1

  Cellares and City of Hope are collaborating to automate the manufacturing of CAR T cell therapy for glioblastoma multiforme.

• 2

  City of Hope is a leader in CAR T therapy for glioblastoma, having pioneered direct injection methods for treatment.

• 3

  The collaboration will utilize Cellares’ automated manufacturing platform to enhance the CARpool program's production efficiency.

• 4

  Automation aims to standardize processes and analytics, improving the consistency and scalability of CAR T therapies.

• 5

  This partnership addresses the challenges of glioblastoma treatment by enhancing manufacturing capabilities for broader patient access.